Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 170,668 | 781,643 | 655,028 | 490,334 | 205,718 |
| Depreciation Amortization | 178,071 | 732,602 | 538,534 | 344,120 | 172,944 |
| Income taxes - deferred | -3,621 | -75,669 | -35,637 | 9,069 | -41 |
| Accounts receivable | 81,850 | -148,394 | -135,632 | -132,043 | -66,270 |
| Accounts payable and accrued liabilities | -20,535 | 87,481 | 38,870 | 24,517 | 21,402 |
| Other Working Capital | 83,158 | 101 | -30,599 | -350,548 | -86,708 |
| Other Operating Activity | -27,034 | 186,806 | 190,284 | 124,867 | 75,150 |
| Operating Cash Flow | $462,557 | $1,564,570 | $1,220,848 | $510,316 | $322,195 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 45,615 | -58,487 | -57,264 | -80,350 | 6,117 |
| PPE Investments | -134,231 | -603,429 | -409,391 | -150,632 | -111,755 |
| Net Acquisitions | N/A | -57,308 | 72,277 | -9,491 | -5,166 |
| Purchase Of Investment | -32,904 | -31,885 | -28,176 | -23,806 | -8,032 |
| Sale Of Investment | 3,856 | N/A | 3,763 | N/A | N/A |
| Purchase Sale Intangibles | N/A | 117,582 | N/A | N/A | N/A |
| Other Investing Activity | 1,120 | 120,762 | 1,708 | 1,047 | 470 |
| Investing Cash Flow | $-116,544 | $-630,347 | $-417,083 | $-263,232 | $-118,366 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 611,829 | 2,393,116 | 1,705,913 | 1,182,911 | 354,285 |
| Debt Repayment | -880,552 | -2,404,395 | -1,557,358 | -841,687 | -398,990 |
| Common Stock Issued | -7,902 | 18,577 | -42,248 | -47,866 | -501 |
| Common Stock Repurchased | N/A | -802,228 | -802,228 | -617,432 | -236,232 |
| Other Financing Activity | 713 | -326,198 | -194,307 | -120,891 | -60,133 |
| Financing Cash Flow | $-275,912 | $-1,121,128 | $-890,228 | $-444,965 | $-341,571 |
| Exchange Rate Effect | 2,307 | -29,066 | -6,283 | -1,342 | 3,363 |
| Beginning Cash Position | 338,989 | 554,960 | 554,960 | 554,960 | 554,960 |
| End Cash Position | 411,397 | 338,989 | 462,214 | 355,737 | 420,581 |
| Net Cash Flow | $72,408 | $-215,971 | $-92,746 | $-199,223 | $-134,379 |
| Free Cash Flow | |||||
| Operating Cash Flow | 462,557 | 1,564,570 | 1,220,848 | 510,316 | 322,195 |
| Capital Expenditure | -147,705 | -603,429 | -409,391 | -265,461 | -123,108 |
| Free Cash Flow | 314,852 | 961,141 | 811,457 | 244,855 | 199,087 |